HBK Investments L P Buys New Stake in Aramark (ARMK)

HBK Investments L P bought a new stake in shares of Aramark (NYSE:ARMK) in the fourth quarter, HoldingsChannel reports. The institutional investor bought 30,100 shares of the company’s stock, valued at approximately $1,286,000.

Other large investors also recently added to or reduced their stakes in the company. Cerebellum GP LLC bought a new stake in shares of Aramark during the 4th quarter valued at $127,000. Advisor Group Inc. lifted its position in shares of Aramark by 85.7% during the 3rd quarter. Advisor Group Inc. now owns 3,342 shares of the company’s stock valued at $136,000 after acquiring an additional 1,542 shares during the period. Fuller & Thaler Asset Management Inc. lifted its position in shares of Aramark by 91.7% during the 4th quarter. Fuller & Thaler Asset Management Inc. now owns 3,450 shares of the company’s stock valued at $147,000 after acquiring an additional 1,650 shares during the period. SG Americas Securities LLC lifted its position in shares of Aramark by 54.9% during the 4th quarter. SG Americas Securities LLC now owns 3,954 shares of the company’s stock valued at $169,000 after acquiring an additional 1,401 shares during the period. Finally, Highlander Capital Management LLC bought a new stake in shares of Aramark during the 3rd quarter valued at $203,000. Hedge funds and other institutional investors own 94.69% of the company’s stock.

How to Become a New Pot Stock Millionaire

Aramark stock opened at $40.81 on Thursday. The company has a current ratio of 1.40, a quick ratio of 1.09 and a debt-to-equity ratio of 2.56. Aramark has a fifty-two week low of $36.06 and a fifty-two week high of $46.09. The company has a market capitalization of $10,091.38, a price-to-earnings ratio of 22.81, a PEG ratio of 1.72 and a beta of 0.60.

Aramark (NYSE:ARMK) last posted its quarterly earnings results on Tuesday, February 6th. The company reported $0.54 EPS for the quarter, topping analysts’ consensus estimates of $0.51 by $0.03. Aramark had a return on equity of 18.68% and a net margin of 3.65%. The company had revenue of $3.97 billion during the quarter, compared to analysts’ expectations of $3.88 billion. During the same quarter in the previous year, the firm earned $0.55 EPS. Aramark’s revenue was up 6.2% on a year-over-year basis. research analysts expect that Aramark will post 1.99 earnings per share for the current fiscal year.

The firm also recently declared a quarterly dividend, which was paid on Thursday, March 1st. Stockholders of record on Wednesday, February 14th were issued a dividend of $0.105 per share. The ex-dividend date was Tuesday, February 13th. This represents a $0.42 dividend on an annualized basis and a dividend yield of 1.03%. Aramark’s dividend payout ratio (DPR) is currently 19.53%.

ARMK has been the subject of a number of recent analyst reports. Zacks Investment Research upgraded Aramark from a “sell” rating to a “hold” rating in a research report on Wednesday, November 22nd. Credit Suisse Group reiterated an “outperform” rating and set a $50.00 target price on shares of Aramark in a research report on Wednesday, January 24th. Royal Bank of Canada reiterated a “buy” rating and set a $51.00 target price on shares of Aramark in a research report on Friday, January 19th. Morgan Stanley upped their target price on Aramark from $41.00 to $42.00 and gave the company an “equal weight” rating in a research report on Wednesday, January 31st. Finally, Barclays upped their target price on Aramark from $45.00 to $47.00 and gave the company an “equal weight” rating in a research report on Friday, December 22nd. Three equities research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. The stock has an average rating of “Buy” and an average target price of $47.43.

WARNING: This piece was originally reported by Ticker Report and is the sole property of of Ticker Report. If you are accessing this piece on another publication, it was copied illegally and reposted in violation of international copyright & trademark legislation. The legal version of this piece can be viewed at https://www.tickerreport.com/banking-finance/3288933/hbk-investments-l-p-buys-new-stake-in-aramark-armk.html.

About Aramark

Aramark is a global provider of food, facilities and uniform services to education, healthcare, business and industry, and sports, leisure and corrections clients. The Company operates through three segments: Food and Support Services North America (FSS North America), Food and Support Services International (FSS International), and Uniform and Career Apparel (Uniform).

Want to see what other hedge funds are holding ARMK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aramark (NYSE:ARMK).

Institutional Ownership by Quarter for Aramark (NYSE:ARMK)

Receive News & Ratings for Aramark Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aramark and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Cantor Fitzgerald Raises Intuitive Surgical  Price Target to $510.00
Cantor Fitzgerald Raises Intuitive Surgical Price Target to $510.00
JPMorgan Chase Boosts UnitedHealth Group  Price Target to $266.00
JPMorgan Chase Boosts UnitedHealth Group Price Target to $266.00
Mizuho Reaffirms “Buy” Rating for QUALCOMM
Mizuho Reaffirms “Buy” Rating for QUALCOMM
Noah  and PJT Partners  Critical Review
Noah and PJT Partners Critical Review
Head-To-Head Analysis: The Meet Group  & Quotient Technology
Head-To-Head Analysis: The Meet Group & Quotient Technology
Mersana Therapeutics  Stock Rating Upgraded by Zacks Investment Research
Mersana Therapeutics Stock Rating Upgraded by Zacks Investment Research


© 2006-2018 Ticker Report. Google+.